{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T10:43:26Z","timestamp":1791110606685,"version":"4.1.0"},"reference-count":51,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2024,5]]},"DOI":"10.1016\/j.ejmech.2024.116399","type":"journal-article","created":{"date-parts":[[2024,4,11]],"date-time":"2024-04-11T08:09:52Z","timestamp":1712822992000},"page":"116399","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Identification of CH2-linked quinolone-aminopyrimidine hybrids as potent anti-MRSA agents: Low resistance potential and lack of cross-resistance with fluoroquinolone antibiotics"],"prefix":"10.1016","volume":"271","author":[{"given":"Hongxue","family":"Dai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiwen","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renhua","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9744-9573","authenticated-orcid":false,"given":"Qiuqin","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2024.116399_bib1a","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1126\/science.352.6287.758","article-title":"Resistance fighters","volume":"352","author":"Kupferschmidt","year":"2016","journal-title":"Science"},{"key":"10.1016\/j.ejmech.2024.116399_bib1b","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1021\/acsinfecdis.2c00253","article-title":"Recent Advances in the Development of semisynthetic glycopeptide antibiotics: 2014-2022","volume":"8","author":"van Groesen","year":"2022","journal-title":"ACS Infect. Dis."},{"key":"10.1016\/j.ejmech.2024.116399_bib2a","unstructured":"Centers for Disease Control and Prevention. https:\/\/www.cdc.gov\/drugresistance\/pdf\/threats-report\/2019-ar-threats-report-508.pdf (accessed October 5, 2021)."},{"key":"10.1016\/j.ejmech.2024.116399_bib2b","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.annemergmed.2004.10.011","article-title":"High Prevalence of methicillin-resistant Staphylococcus aureus in emergency department skin and soft tissue infections","volume":"45","author":"Frazee","year":"2005","journal-title":"Ann. Emerg. Med."},{"key":"10.1016\/j.ejmech.2024.116399_bib2c","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1056\/NEJMe058023","article-title":"Community-associated MRSA-resistance and virulence converge","volume":"352","author":"Chambers","year":"2005","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ejmech.2024.116399_bib2d","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1056\/NEJMoa055356","article-title":"Methicillin-resistant, aureus infections among patients in the emergency department","volume":"355","author":"Moran","year":"2006","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ejmech.2024.116399_bib3","doi-asserted-by":"crossref","first-page":"S5","DOI":"10.1086\/491709","article-title":"Vancomycin: a history","volume":"42","author":"Levine","year":"2006","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.ejmech.2024.116399_bib4a","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1086\/317542","article-title":"Vancomycin intermediate and resistant S aureus: what infectious disease specialists need to know","volume":"32","author":"Fridkin","year":"2001","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.ejmech.2024.116399_bib4b","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1002\/cjoc.201800470","article-title":"Chemical intervention on Staphylococcus aureus virulence","volume":"37","author":"Zhou","year":"2019","journal-title":"Chin. J. Chem."},{"key":"10.1016\/j.ejmech.2024.116399_bib5a","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2021.113442","article-title":"A key review on oxadiazole analogs as potential methicillin-resistant Staphylococcus aureus (MRSA) activity: structure-activity relationship studies","volume":"219","author":"Verma","year":"2021","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116399_bib5b","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2020.113134","article-title":"Pyrazole-based analogs as potential antibacterial agents against methicillin-resistance staphylococcus aureus (MRSA) and its SAR elucidation","volume":"212","author":"Verma","year":"2021","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116399_bib5c","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2021.105175","article-title":"Benzimidazole analogues as efffcient arsenals in war against methicillin-resistance staphylococcus aureus (MRSA) and its SAR studies","volume":"115","author":"Zha","year":"2021","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2024.116399_bib5d","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2023.106975","article-title":"Fluorinated azoles as effective weapons in ffght against methicillin-resistance staphylococcus aureus (MRSA) and its SAR studies","volume":"143","author":"Zhao","year":"2024","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2024.116399_bib5e","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2024.116274","article-title":"Novel membrane-targeting isoxanthohumol-amine conjugates for combating methicillin-resistant Staphylococcus aureus (MRSA) infections","volume":"268","author":"Yang","year":"2024","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116399_bib5f","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1021\/acs.jmedchem.3c01360","article-title":"Development of antibacterial peptides with membrane disruption and folate pathway inhibitory activities against methicillin-resistant Staphylococcus aureus","volume":"67","author":"Li","year":"2024","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116399_bib5g","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1021\/acs.jmedchem.3c02064","article-title":"Discovery of unique bis-substituted aromatic amide derivatives as novel highly potent antibiotics for combating methicillin-resistant Staphylococcus aureus (MRSA)","volume":"67","author":"Guo","year":"2024","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116399_bib6a","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1128\/AAC.23.4.559","article-title":"In vitro antibacterial activity of Bay 09867, a new quinolone derivative, compared with those of other antimicrobial agents","volume":"23","author":"Wise","year":"1983","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejmech.2024.116399_bib6b","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1002\/jlac.198719870106","article-title":"Cycloaracylation of enamines. I. Synthesis of 4-quinolone-3-carboxylic acids","volume":"3","author":"Grohe","year":"1987","journal-title":"Liebigs Ann. Chem."},{"key":"10.1016\/j.ejmech.2024.116399_bib7a","doi-asserted-by":"crossref","first-page":"1896","DOI":"10.1248\/cpb.35.1896","article-title":"Synthesis and antibacterial activity of optically active ofloxacin and its fluoromethyl derivative","volume":"35","author":"Atarashi","year":"1987","journal-title":"Chem. Pharm. Bull."},{"key":"10.1016\/j.ejmech.2024.116399_bib7b","first-page":"559","article-title":"Synthesis and antibacterial activity of optically active ofloxacin","volume":"32","author":"Une","year":"1988","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejmech.2024.116399_bib8","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/978-1-4939-7459-7_3","article-title":"DNA topoisomerases as targets for antibacterial agents","volume":"1703","author":"Hiasa","year":"2018","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.ejmech.2024.116399_bib9","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0012245","article-title":"Structural insights into the quinolone resistance mechanism of mycobacterium tuberculosis DNA Gyrase","volume":"5","author":"Piton","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.ejmech.2024.116399_bib10a","doi-asserted-by":"crossref","first-page":"2558","DOI":"10.1128\/AAC.02794-15","article-title":"Antimicrobial activities of ceftaroline and comparator agents against bacterial organisms causing bacteremia in patients with skin and skin structure infections in U.S. medical centers, 2008 to 2014","volume":"60","author":"Sader","year":"2016","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejmech.2024.116399_bib10b","doi-asserted-by":"crossref","first-page":"2273","DOI":"10.1128\/AAC.02803-15","article-title":"Linezolid surveillance results for the United States (LEADER surveillance program 2014)","volume":"60","author":"Flamm","year":"2016","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejmech.2024.116399_bib11a","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/S0014-2999(00)00693-2","article-title":"Effects of fluoroquinolones on hERG currents","volume":"406","author":"Bischoff","year":"2000","journal-title":"Eur. J. Pharmcol."},{"key":"10.1016\/j.ejmech.2024.116399_bib11b","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1093\/jac\/49.4.593","article-title":"Cardiotoxicity of fluoroquinolones","volume":"49","author":"Rubinstein","year":"2002","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.ejmech.2024.116399_bib12a","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1128\/AAC.01617-06","article-title":"Quinolone-mediated bacterial death","volume":"52","author":"Drlica","year":"2008","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejmech.2024.116399_bib12b","doi-asserted-by":"crossref","first-page":"981","DOI":"10.2174\/156802609789630947","article-title":"Quinolones: action and resistance updated","volume":"9","author":"Drlica","year":"2009","journal-title":"Curr. Top. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116399_bib13","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1021\/bi5000564","article-title":"Mechanism of quinolone action and resistance","volume":"53","author":"Aldred","year":"2014","journal-title":"Biochemistry"},{"key":"10.1016\/j.ejmech.2024.116399_bib14a","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejmech.2019.04.033","article-title":"1,2,4-Triazole-quinoline\/quinolone hybrids as potential anti-bacterial agents","volume":"174","author":"Zhang","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116399_bib14b","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2022.115026","article-title":"Current scenario of quinolone hybrids with potential antibacterial activity against ESKAPE pathogens","volume":"247","author":"Gao","year":"2023","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116399_bib15a","doi-asserted-by":"crossref","first-page":"4411","DOI":"10.1021\/acs.jmedchem.8b01923","article-title":"Exploitation of antibiotic resistance as a novel drug target: development of a \u03b2-lactamase-activated antibacterial prodrug","volume":"62","author":"Evans","year":"2019","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116399_bib15b","doi-asserted-by":"crossref","first-page":"5634","DOI":"10.1038\/s41598-019-42155-4","article-title":"Structural basis of translation inhibition by cadazolid, a novel quinoxolidinone antibiotic","volume":"9","author":"Scaiola","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejmech.2024.116399_bib15c","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2021.113340","article-title":"Membrane active 7-thiazoxime quinolones as novel DNA binding agents to decrease the genes expression and exert potent anti-methicillin-resistant Staphylococcus aureus activity","volume":"217","author":"Chen","year":"2021","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116399_bib15d","doi-asserted-by":"crossref","DOI":"10.1002\/slct.202201565","article-title":"Synthesis, antibacterial evaluation and molecular docking studies of 1,3,4-oxadiazole-2 (3H)-thione-norfloxacin hybrids as potent antibacterial agents","volume":"7","author":"Luo","year":"2022","journal-title":"ChemistrySelect"},{"key":"10.1016\/j.ejmech.2024.116399_bib15e","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2023.115373","article-title":"Antibacterial and antibiofilm activity of permanently ionized quaternary ammonium fluoroquinolones","volume":"254","author":"Fedorowicz","year":"2023","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116399_bib16","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2020.104176","article-title":"Design and synthesis of novel desfluoroquinolone-aminopyrimidine hybrids as potent anti-MRSA agents with low hERG activity","volume":"103","author":"Song","year":"2020","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2024.116399_bib17","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1042\/bj0630634","article-title":"The enzymic cleavage of aromatic ethers","volume":"63","author":"Axelrod","year":"1956","journal-title":"Biochem. J."},{"key":"10.1016\/j.ejmech.2024.116399_bib18","doi-asserted-by":"crossref","first-page":"3194","DOI":"10.1021\/jm0402061","article-title":"Synthesis and antibacterial activity of 1-(2-fluorovinyl)-7-substituted-4-quinolone-3-carboxylic acid derivatives, conformationally restricted analogues of fleroxacin","volume":"48","author":"Asahina","year":"2005","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116399_bib19","doi-asserted-by":"crossref","first-page":"2601","DOI":"10.1021\/jm100087s","article-title":"Intramolecular hydrogen bonding in medicinal chemistry","volume":"53","author":"Kuhn","year":"2010","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116399_bib20","doi-asserted-by":"crossref","first-page":"2321","DOI":"10.1128\/AAC.40.10.2321","article-title":"Involvement of topoisomerase IV and DNA gyrase as ciprofloxacin targets in Streptococcus pneumoniae","volume":"40","author":"Pan","year":"1996","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejmech.2024.116399_bib21","doi-asserted-by":"crossref","first-page":"2317","DOI":"10.1111\/j.1540-8159.2003.00367.x","article-title":"Quinolones: cardioprotective or cardiotoxic?","volume":"26","author":"Katritsis","year":"2003","journal-title":"Pacing Clin. Electrophysiol."},{"key":"10.1016\/j.ejmech.2024.116399_bib22","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/j.ejmech.2017.01.012","article-title":"The synthesis and antistaphylococcal activity of 9, 13-disubstituted berberine derivatives","volume":"127","author":"Wang","year":"2017","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116399_bib23","series-title":"Gaussian 09 Rev. E.01, Wallingford, CT","author":"Frisch","year":"2016"},{"key":"10.1016\/j.ejmech.2024.116399_bib24","doi-asserted-by":"crossref","DOI":"10.1063\/1.3382344","article-title":"A consistent and accurate ab initio parametrization of density functional dispersion correction (DFT-D) for the 94 elements H-Pu","volume":"132","author":"Grimme","year":"2010","journal-title":"J. Chem. Phys."},{"key":"10.1016\/j.ejmech.2024.116399_bib25a","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1002\/jcc.21759","article-title":"Effect of the damping function in dispersion corrected density functional theory","volume":"32","author":"Grimme","year":"2011","journal-title":"J. Comput. Chem."},{"key":"10.1016\/j.ejmech.2024.116399_bib25b","doi-asserted-by":"crossref","DOI":"10.1063\/1.2190220","article-title":"A post-Hartree-Fock model of intermolecular interactions: inclusion of higher-order corrections","volume":"124","author":"Johnson","year":"2006","journal-title":"J. Chem. Phys."},{"key":"10.1016\/j.ejmech.2024.116399_bib25c","doi-asserted-by":"crossref","DOI":"10.1063\/1.1949201","article-title":"A post-Hartree-Fock model of intermolecular interactions","volume":"123","author":"Johnson","year":"2005","journal-title":"J. Chem. Phys."},{"key":"10.1016\/j.ejmech.2024.116399_bib25d","doi-asserted-by":"crossref","DOI":"10.1063\/1.2065267","article-title":"A density-functional model of the dispersion interaction","volume":"123","author":"Becke","year":"2005","journal-title":"J. Chem. Phys."},{"key":"10.1016\/j.ejmech.2024.116399_bib26","doi-asserted-by":"crossref","first-page":"6378","DOI":"10.1021\/jp810292n","article-title":"Universal solvation model based on solute electron density and on a continuum model of the solvent defined by the bulk dielectric constant and atomic surface tensions","volume":"113","author":"Marenich","year":"2009","journal-title":"J. Phys. Chem. B"},{"key":"10.1016\/j.ejmech.2024.116399_bib27","doi-asserted-by":"crossref","first-page":"4558","DOI":"10.1021\/jm500270w","article-title":"Membrane active vancomycin analogues: a strategy to combat bacterial resistance","volume":"57","author":"Yarlagadda","year":"2014","journal-title":"J. Med. Chem."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523424002794?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523424002794?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T09:32:50Z","timestamp":1717234370000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523424002794"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5]]},"references-count":51,"alternative-id":["S0223523424002794"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2024.116399","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2024,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Identification of CH2-linked quinolone-aminopyrimidine hybrids as potent anti-MRSA agents: Low resistance potential and lack of cross-resistance with fluoroquinolone antibiotics","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2024.116399","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"116399"}}